Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-09 Purchase |
2025-06-10 5:26 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
100,000 | $0.7008 | $70,080 | 1,079,891 (Indirect Direct) |
View |
| 2025-06-06 Purchase |
2025-06-10 5:23 pm |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
20,000 | $0.576 | $11,520 | 81,983 (Indirect Direct) |
View |
| 2025-06-06 Purchase |
2025-06-10 5:22 pm |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
40,010 | $0.637 | $25,486 | 80,010 (Direct) |
View |
| 2023-02-21 Purchase |
2023-02-21 8:05 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,823 | $0.8415 | $4,900 | 979,891 (Indirect Direct) |
View |
| 2023-02-13 Purchase |
2023-02-13 4:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,606 | $0.8742 | $4,901 | 974,068 (Indirect Direct) |
View |
| 2023-02-06 Purchase |
2023-02-06 4:03 pm |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
5,040 | $0.9723 | $4,900 | 968,462 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-12 Option Award |
2025-06-12 5:30 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | Pasternak Andy Director |
138,900 | $0 | 138,900 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-12 5:28 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director |
123,500 | $0 | 123,500 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-12 5:27 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | Smith Karen L. Director |
123,500 | $0 | 123,500 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-12 5:25 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director |
123,500 | $0 | 123,500 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-12 5:24 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | Walker Luke Nathaniel Director |
123,500 | $0 | 123,500 (Direct) |
View |
| 2025-06-12 Option Award |
2025-06-12 5:23 pm |
N/A 2035-06-11 |
Context Therapeutics Inc. | CNTX | West Linda Director |
123,500 | $0 | 123,500 (Direct) |
View |
| 2025-06-09 Option Award |
2025-06-09 5:22 pm |
N/A 2035-06-08 |
Context Therapeutics Inc. | CNTX | Chagin Karen Deborah Chief Medical Officer |
153,000 | $0 | 153,000 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-14 4:13 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
371,800 | $0 | 371,800 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-14 4:11 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
349,900 | $0 | 349,900 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-14 4:07 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Dansky Ullmann Claudio Chief Medical Officer |
174,960 | $0 | 174,960 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-14 4:06 pm |
N/A 2035-02-12 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
802,700 | $0 | 802,700 (Direct) |
View |
| 2025-01-13 Option Award |
2025-01-14 8:43 pm |
N/A 2035-01-12 |
Context Therapeutics Inc. | CNTX | Pasternak Andy Director |
20,685 | $0 | 20,685 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-05 08:15 am |
N/A 2034-09-03 |
Context Therapeutics Inc. | CNTX | Smith Karen L. Director |
19,315 | $0 | 19,315 (Direct) |
View |
| 2024-09-04 Option Award |
2024-09-05 08:04 am |
N/A 2034-09-03 |
Context Therapeutics Inc. | CNTX | Walker Luke Nathaniel Director |
19,315 | $0 | 19,315 (Direct) |
View |
| 2024-08-01 Option Award |
2024-08-01 5:18 pm |
N/A 2034-07-31 |
Context Therapeutics Inc. | CNTX | Dansky Ullmann Claudio Chief Medical Officer |
202,170 | $0 | 202,170 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 07:52 am |
N/A 2034-06-12 |
Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 07:50 am |
N/A 2034-06-12 |
Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 07:47 am |
N/A 2034-06-12 |
Context Therapeutics Inc. | CNTX | West Linda Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 07:41 am |
N/A 2034-06-12 |
Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-22 08:04 am |
N/A 2034-03-20 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
160,115 | $0 | 160,115 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-22 08:01 am |
N/A 2034-03-20 |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
153,515 | $0 | 153,515 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-22 08:01 am |
N/A 2034-03-20 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
291,402 | $0 | 291,402 (Direct) |
View |
| 2023-05-31 Option Award |
2023-05-31 4:53 pm |
N/A 2033-05-30 |
Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-31 Option Award |
2023-05-31 4:53 pm |
N/A 2033-05-30 |
Context Therapeutics Inc. | CNTX | West Linda Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-31 Option Award |
2023-05-31 4:53 pm |
N/A 2033-05-30 |
Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-05-31 Option Award |
2023-05-31 4:52 pm |
N/A 2033-05-30 |
Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-14 5:04 pm |
N/A 2033-02-12 |
Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec |
151,505 | $0 | 151,505 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-14 5:04 pm |
N/A 2033-02-12 |
Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer |
287,544 | $0 | 287,544 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-14 5:04 pm |
N/A 2033-02-12 |
Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer |
158,001 | $0 | 158,001 (Direct) |
View |